“Goal-directed therapy can reduce the risk of Postoperative AKI”… says a newly published article in Nature (Nature Reviews Nephrology). The Acute Disease Quality Initiative (ADQI-24) and the PeriOperative Quality Initiative (POQI-7)…
AKI “Canary in the Coalmine” for Cellular Injury
Surgical backlog discussed in TopMedTalk podcast: The second of two Deltex-sponsored podcasts is now available on TopMedTalk. The panel turns to efficiency and effectiveness as vital in tackling the weight…
Liver Transplantation with Haemodynamic Control of Lung Recruitment
24th ODM+ RCT shows benefit in Liver Transplantation: Yet another Randomised Controlled Trial (RCT) demonstrates the value of Deltex Medical’s TrueVue Oesophageal Doppler Monitoring (ODM+). Once more it’s in a…
Deltex Medical Sponsors Return to Surgery Podcasts
Luminary speakers discuss the return to surgery in the wake of COVID-19. Haemodynamic monitoring technology leader, Deltex Medical is solely supporting a series of podcasts as clinicians manage the return…
Only ODM+ has the Precision, concludes new Study
Direct comparison between three monitoring technologies says only ODM+ picks up outcome-determining haemodynamic changes. We’ve covered the RELIEF study on our news pages before, here. The paper, from Myles et…
MDR Equivalence Rules Reinforce Deltex’s Unique Evidence Base
Deltex Medical’s Oesophageal Doppler Monitoring system (ODM+) stands out from the crowd in important ways that are highly relevant when it comes to MDR assessment. Not least in the way…
Deltex Medical Joins UK Healthcare Pavilion Digital Platform
The new UK Digital Healthcare Pavilion describes itself as a unique partnering platform. Its mission is to help overseas customers discover, connect and innovate with the UK’s thriving healthcare and…
Haemodynamics Matter: New Study, Same Take-Homes
ICU Patient Study Points to Monitoring… Open access, peer-reviewed publication PLOS (Public Library Of Science), brings us a new and illuminating COVID-19 study. And again one clear take-home message is…
23rd ODM+ RCT shows benefit in Obese Patients
A newly published randomised controlled trial (RCT) is the 23rd to reinforce the important contribution of oesophageal Doppler monitoring (ODM+). The study evaluates haemodynamic management in obese surgical patients. Obesity…
Putting the “E” into EBPOM
When it comes to evidence, few technologies are as well supported as Deltex Medical’s Oesophageal Doppler Monitoring (ODM+) system as featured in the company’s TrueVue haemodynamic management system. So it’s…
